AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
159 hedge funds and large institutions have $836M invested in Avadel Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 69 increasing their positions, 39 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
15% less capital invested
Capital invested by funds: $979M → $836M (-$143M)
40% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 40
Holders
159
Holding in Top 10
7
Calls
$26.4M
Puts
$12.9M
Top Buyers
| 1 | +$24.8M | |
| 2 | +$11.7M | |
| 3 | +$9.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$9.15M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$8.7M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$8M | |
| 3 | -$6.41M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$5.1M |
| 5 |
CCM
Cutter Capital Management
New York
|
-$5.05M |